Description

T-6 (complexe ECA + DMAA)

Marque : Tomorrow Pharmaceuticals
Catégorie : High-Stimulant Thermogenic · ECA + DMAA
Contenu : 90 capsules
Per Capsule: Ephedrine 30 mg · Caffeine 250 mg · Aspirin 150 mg · 1,3-DMAA 50 mg
Origin: Cyprus
Prix : €25
Research Notice: For laboratory use only. Not for human or veterinary consumption.

🧪 Aperçu du produit

T-6 is a reinforced ECA stack upgraded with 1,3-DMAA, delivering a fast, hard-hitting stimulant response suitable for controlled thermogenic and adrenergic-activation research.
It is intended for advanced stimulant-tolerant researchers evaluating:

• maximum-intensity thermogenesis
• β-adrenergic activation pathways
• appetite-control models
• pre-exercise arousal and focus studies
• multi-stimulant synergy (E+C+A+DMAA)

This formula is significantly stronger than standard EC stacks due to the inclusion of DMAA.

✅ Principaux résultats de la recherche

Ephedrine (30 mg):
A classic sympathomimetic that increases synaptic norepinephrine → heightened alertness, thermogenesis, and metabolic output. Human studies repeatedly show increased energy expenditure when ephedrine is combined with caffeine.

Caffeine (250 mg):
Non-selective adenosine A1/A2A antagonist that elevates wakefulness, reduces fatigue perception, increases neural drive, and potentiates ephedrine’s thermogenic effects.

Aspirin (150 mg):
Historically used in ECA triads; explored for its potential to sustain ephedrine-induced thermogenesis through prostaglandin-related pathways (evidence variable).

DMAA (50 mg):
A potent indirect sympathomimetic associated with rapid onset CNS stimulation. Several regulatory authorities deem DMAA unlawful in supplements and prohibit its sport use.

🧬 Mécanisme d'action (simplifié)

• Ephedrine: Boosts norepinephrine release → β-adrenergic stimulation → increased heat production, energy, and lipolysis.
• Caffeine: Blocks adenosine receptors → heightened CNS activity + stronger ephedrine thermogenesis.
• Aspirin: Explored as a thermogenesis potentiator in classic ECA studies.
• DMAA: Strong sympathomimetic → sharp CNS elevation and adrenergic output.

📊 Tableau des spécifications techniques

📚 Research Background

• Ephedrine + caffeine synergy: Human studies show enhanced thermogenesis, higher metabolic rate, and reduced energy intake.
• Caffeine reviews: Strong literature support for CNS stimulation and metabolic modulation.
• Aspirin effects: Mechanistic analyses explore its role in sustaining ephedrine thermogenesis.
• DMAA: Recognized as a potent stimulant with safety concerns leading to major regulatory restrictions.

⚠️ Potential Side Effects (Class-Based Literature)

• Rapid heartbeat, high blood pressure, palpitations
• Insomnia, anxiety, tremor, agitation
• Headache, nausea, or dizziness
• Sympathomimetic overload when combined with other stimulants
• Rare severe events: arrhythmia, stroke, myocardial infarction

🧯 Compliance & Sport Integrity

Anti-doping:
Ephedrine and DMAA are prohibited in-competition under WADA rules (ephedrine threshold 10 µg/mL).
Athletes risk sanctions if exposed.

Regulatory:
FDA bans ephedrine-alkaloid supplements and classifies DMAA supplements as adulterated/illegal.
Several countries enforce similar restrictions.

Research-only:
This item is supplied strictly for laboratory and analytical use.
Not a dietary supplement or performance enhancer.

📌 Important Safety Notice

For research use only.
Not for human consumption. Not for medical, dietary, or athletic use.
Do not combine with additional stimulants or MAO inhibitors.